ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 2.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $620,000 | -63.6% | 216,024 | -2.6% | 0.00% | – |
| Q2 2019 | $1,701,000 | -42.3% | 221,749 | -0.0% | 0.00% | -100.0% |
| Q1 2019 | $2,948,000 | -14.7% | 221,795 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,456,000 | -33.4% | 221,795 | -16.1% | 0.00% | 0.0% |
| Q3 2018 | $5,192,000 | -30.9% | 264,243 | +0.9% | 0.00% | -50.0% |
| Q2 2018 | $7,518,000 | +48.3% | 261,956 | +22.2% | 0.00% | +100.0% |
| Q1 2018 | $5,070,000 | +173.3% | 214,387 | +147.9% | 0.00% | – |
| Q4 2017 | $1,855,000 | -11.5% | 86,489 | -2.4% | 0.00% | – |
| Q3 2017 | $2,097,000 | +31.0% | 88,654 | +9.1% | 0.00% | – |
| Q2 2017 | $1,601,000 | -12.7% | 81,256 | -6.9% | 0.00% | – |
| Q1 2017 | $1,833,000 | +31.1% | 87,286 | +17.4% | 0.00% | – |
| Q4 2016 | $1,398,000 | -86.6% | 74,366 | -85.1% | 0.00% | -100.0% |
| Q3 2016 | $10,450,000 | -46.5% | 500,471 | -34.6% | 0.00% | -40.0% |
| Q2 2016 | $19,529,000 | -57.9% | 765,704 | -56.3% | 0.01% | -58.3% |
| Q1 2016 | $46,371,000 | -38.3% | 1,753,191 | -0.3% | 0.01% | -40.0% |
| Q4 2015 | $75,209,000 | +63.1% | 1,758,036 | +1.1% | 0.02% | +53.8% |
| Q3 2015 | $46,105,000 | -22.4% | 1,739,168 | -2.4% | 0.01% | -13.3% |
| Q2 2015 | $59,382,000 | -7.5% | 1,781,632 | -7.7% | 0.02% | -11.8% |
| Q1 2015 | $64,208,000 | -3.7% | 1,929,307 | +18.2% | 0.02% | -5.6% |
| Q4 2014 | $66,706,000 | +78.0% | 1,632,169 | +47.6% | 0.02% | +80.0% |
| Q3 2014 | $37,476,000 | -9.6% | 1,106,144 | -10.1% | 0.01% | -9.1% |
| Q2 2014 | $41,463,000 | -7.1% | 1,229,991 | +4.4% | 0.01% | -8.3% |
| Q1 2014 | $44,650,000 | +27.4% | 1,177,803 | -1.8% | 0.01% | +20.0% |
| Q4 2013 | $35,036,000 | -25.1% | 1,199,853 | -12.1% | 0.01% | -33.3% |
| Q3 2013 | $46,804,000 | +13.7% | 1,365,333 | +9.4% | 0.02% | +15.4% |
| Q2 2013 | $41,180,000 | – | 1,248,256 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |